Accuray Incorporated (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
0.1100
-0.0139 (-11.22%)
At close: Nov 6, 2026, 4:00 PM EST
0.1150
+0.0050 (4.55%)
After-hours: Nov 6, 2026, 7:48 PM EST
Accuray Revenue
Accuray had revenue of $86.52M in the quarter ending September 30, 2026, a decrease of -7.90%. This brings the company's total for the last twelve months to $394.53M, down -12.50% year-over-year. In the fiscal year ending June 30, 2026, Accuray had annual revenue of $401.95M, down -12.34%. That makes Accuray the 12,703rd largest company in the world by revenue and 2,438th in the United States.
Revenue (ttm)
$394.53M
Revenue Growth
-12.50%
P/S Ratio
0.03
Revenue / Employee
$487,674
Employees
809
Market Cap
13.15M
Revenue by Geography
- Europe India Middle East and Africa 150.91M 37.5%
- Americas 89.96M 22.4%
- China 68.14M 17.0%
- Asia Pacific, Excluding Japan and China 48.68M 12.1%
- Japan 44.26M 11.0%
Fiscal year ended Jun 30, 2026 See the full Accuray breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 401.95M | -56.56M | -12.34% |
| Jun 30, 2025 | 458.51M | 11.95M | 2.68% |
| Jun 30, 2024 | 446.55M | -1.05M | -0.24% |
| Jun 30, 2023 | 447.61M | 17.70M | 4.12% |
| Jun 30, 2022 | 429.91M | 33.62M | 8.48% |
| Jun 30, 2021 | 396.29M | 13.36M | 3.49% |
| Jun 30, 2020 | 382.93M | -35.86M | -8.56% |
| Jun 30, 2019 | 418.79M | 13.89M | 3.43% |
| Jun 30, 2018 | 404.90M | 21.48M | 5.60% |
| Jun 30, 2017 | 383.41M | -15.39M | -3.86% |
| Jun 30, 2016 | 398.80M | 19.00M | 5.00% |
| Jun 30, 2015 | 379.80M | 10.38M | 2.81% |
| Jun 30, 2014 | 369.42M | 53.45M | 16.91% |
| Jun 30, 2013 | 315.97M | -93.25M | -22.79% |
| Jun 30, 2012 | 409.22M | 186.94M | 84.10% |
| Jun 30, 2011 | 222.28M | 659.00K | 0.30% |
| Jun 30, 2010 | 221.63M | -11.97M | -5.13% |
| Jun 30, 2009 | 233.60M | 23.22M | 11.04% |
| Jun 30, 2008 | 210.38M | 69.93M | 49.79% |
| Jun 30, 2007 | 140.45M | 87.56M | 165.52% |
| Jun 30, 2006 | 52.90M | 30.52M | 136.39% |
| Jun 30, 2005 | 22.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IRIDEX | 51.57M |
| SANUWAVE Health | 44.02M |
| Cytosorbents | 37.22M |
| Lifeward | 21.82M |
| Nano-X Imaging | 15.63M |
| Pulsenmore | 14.13M |
| Sintx Technologies | 3.31M |
| iTonic Holdings | 556.43K |
ARAY News
- 1 day ago - Accuray trading halted, news pending - TheFly
- 3 days ago - Accuray announces 1-for-40 reverse stock split - TheFly
- 3 days ago - Accuray reports Q3 EPS (10c) ex-items vs. (18c) last year - TheFly
- 3 days ago - Accuray Earnings Call Transcript: Q1 2027 - Transcripts
- 3 days ago - Accuray Earnings release: Q1 2027 - Filings
- 3 days ago - Accuray Slides: Q1 2027 - Filings
- 3 days ago - Accuray Quarterly report: Q1 2027 - Filings
- 3 days ago - Accuray Announces 1-for-40 Reverse Stock Split - PRNewsWire